|
|
Profile
|
Delegates :
Yasunori Aizawa, Taiki Ishikura |
|
Incorporated :
July 1 , 2019 |
Paid in Capital :
100 Million yen |
Employees :
22 人 |
Address :
Harumi 4-7-4, Chuo-ku TOKYO
〒104-0053
|
TEL/FAX :
/ |
URL：
https://logomix.bio/ |
Attachment :
|
Mission/Background :
Logomix is currently creating various versions of artificial cells by its proprietary genome engineering platform Geno-Writing (R) to drive revolution in Pharmaceutical industry for drug discovery, cell therapy, and anti-aging. |
|
Technology & Business
|
Geno-Writing (R) is a genome-writing platform that grants unprecedented freedom to screen, design and write-in large-scale genomic alterations in cells and create new cell types with desired functions.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|